News

TWILIGHT trial will evaluate ticagrelor without aspirin in patients with coronary stents

19.08.20152503

The Icahn School of Medicine at Mount Sinai announced the initiation of a trial that will evaluate the safety and efficacy of ticagrelor monotherapy compared with ticagrelor plus aspirin in patients implanted with a coronary stent.

APPRAISE-2: Apixaban does not affect outcomes, may increase bleeding after ACS

18.08.20151702

In patients with ACS, apixaban did not improve outcomes and was associated with increased bleeding, regardless of background concomitant antiplatelet therapy, according to new findings from the APPRAISE-2 trial.

Warfarin after ischemic stroke improves outcomes, increases time at home for patients with AF

17.08.20151566

Administering warfarin in patients with atrial fibrillation after an ischemic stroke improves long-term clinical outcomes and reduces time spent in a medical facility, according to study results published in the BMJ.

Uric acid levels predict CV events in postmenopausal women

14.08.20151721

High levels of uric acid independently predicted death and major adverse CV events in postmenopausal women, according to recent study findings.

Cardiac troponin T may predict CV events in diabetes, stable ischemic heart disease

13.08.20151580

Abnormal cardiac troponin T concentrations independently predicted CV death, MI or stroke in patients with diabetes and stable ischemic heart disease, according to a new analysis of the BARI 2D study.

Eating spicy foods may reduce total, cause-specific mortality

12.08.20151879

In China, individuals who consumed spicy foods on a regular basis were found to live longer, compared with those who ate spicy food less, according to recently published data in the BMJ.

ENGAGE AF-TIMI 48 subgroup: Amiodarone as adjunct to low-dose edoxaban reduces ischemic events

11.08.20151755

Patients in the ENGAGE AF-TIMI 48 trial who received amiodarone at randomization in addition to a lower-dose regimen of edoxaban experienced a reduction in ischemic events vs. warfarin compared with those on the lower-dose alone, according to research published in the European Heart Journal.